significance of immunostaining data in iga nephropathy patients; current knowledge and new concepts.

IgA Nephropathy and Significance of Immunostaining Data

Significance of immunostaining data in IgA nephropathy patients; current knowledge and new concepts.

Recently much attempts have been directed towards the significance of immunostaining findings and their correlations with clinical and morphologic lesions in IgA nephropathy (IgAN) patients. 1,2 However few investigations have been conducted on this subject. IgAN is the most common glomerulonephritis globally and is a leading cause of chronic kidney disease throughout the world. 2-6 As the most...

iga nephropathy and significance of immunostaining data

0

Significance of vasculopathy in IgA nephropathy patients with regard to Oxford classification and immunostaining findings: a single center experience

INTRODUCTION immunoglobulin A nephropathy is the most common primary glomerulonephritis around the world. It remains poorly understood whether vascular pathology plays an important role in the progression of IgAN. OBJECTIVES Since very few studies regarding vascular disorders in IgAN are published, we aimed to evaluate the role of vascular disease in a group of IgAN patients, especially with ...

Correlation of immunostaining findings with demographic data and variables of Oxford classification in IgA nephropathy.

BACKGROUND Oxford classification for IgA nephropathy (IgAN) did not include pattern of immunostaining in the analysis. OBJECTIVE The aim of this study is to determine the potential correlation between the immunostaining data and morphologic variables of Oxford classification (MEST) and various clinical and demographic data of patients with IgAN. PATIENTS AND METHODS The pathologic diagnosis...

Current therapy for IgA nephropathy.

IgA nephropathy (IgAN) is a very common glomerulonephritis worldwide. In this review, we discuss therapeutic options in four clinical scenarios encountered in patients with IgAN: first is the patient with minor urinary abnormalities where the mainstay of treatment is long-term, regular follow-up to detect renal progression and hypertension. Second is the typical patient presenting with microhem...